If one had bought Palantir on Aug. 8, 2022, a $1,000 investment would be worth about $15,700 today. Three years ago, a ...

Except, that future is the present. A company called Recursion Pharmaceuticals (NASDAQ: RXRX) is doing it. Using its access to 65 petabytes' (65 million gigabytes) worth of biological, chemical, and ...

The stock is up 28% in the last month. It is up close to 600% in the last year. The software provider has produced phenomenal ...

Palantir's enigmatic CEO Alex Karp just made a claim that would sound delusional coming from almost any other tech executive: ...

We recently published 10 Stocks Jim Cramer Mentioned As He Talked About “Love Lost” Between Microsoft & OpenAI. Palantir ...

Palantir's extreme 245x valuation raises risks amidst growth peak concerns. Read more on why caution is key for PLTR ...

Investors should never put too much confidence in forecasts from individual analysts, but Wall Street analysts in aggregate see Palantir as overvalued. The average target price is $151 per share, ...

By now, we all know about Palantir, the one-of-a-kind juggernaut meme stock that can’t be stopped. It’s part sledgehammer, ...

Palantir Technologies shares hit a new all-time high on Friday. The stock is capping an active week driven by a blockbuster ...

Key market indicators currently point to more upside for the S&P 500 ...

Dealing From a Position of Strength Palantir Technologies (NASDAQ:PLTR) has solidified its position as a leader in the ...

Ketchum City Councilman Tripp Hutchinson faced public criticism during Monday’s council meeting for his recent alleged theft ...